Lynparza – Olaparib 50 mg is supplied for Tenders, Emergency imports, Orphan drug, Reference listed drugs, Comparator Drug, Name patient medicine and Innovator samples etc
(Lynparza is registered trademarks Astra Zeneca Pharmaceuticals)
What is LYNPARZA:
Lynparza is a medicine that contains the active substance Olaparib and is available as Capsules (50 mg).
In how many countries LYNPARZA is approved for marketing:
LYNPARZA is available/approved in USA and Europe. We can help you to access it in India.
What is LYNPARZA used for:
Lynparza is indicated as monotherapy in patients with deleterious or suspected deleterious germline BRCA mutated advanced ovarian cancer.
How can I get LYNPARZA in India?
LYNPARZA is a prescription only drug and is not approved for marketing in India.
The Indian Pharma (IP) is a consulting pharmaceutical company which assists Patients in accessing medicines in India. The Indian Pharma facilitates such access only against valid prescriptions in conformity with all local laws and regulations.
Patients/ Clinicians / Researchers can contact IP at +91-120-4080562 or write to at –email@example.com
We facilitate by-
- Helping in documentation to import the medicine for personal use
- Finding Genuine and reliable source in USA, Europe and Japan
- Ensuring 100% transparency.
LYNPARZA can be shipped to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India.
The Indian Pharma can facilitate the supply of LYNPARZA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement.
The Indian Pharma does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees
Can I get LYNPARZA even if I am not based in India?
Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country
The Indian Pharma (IP) can help patients in accessing/importing LYNPARZA, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.
Send your inquiry to find-
- LYNPARZA in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
- LYNPARZA in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
- LYNPARZA in North America – Mexico.
- LYNPARZA in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
- LYNPARZA in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
- LYNPARZA in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
- LYNPARZA in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
- LYNPARZA in Australia and New Zealand.